November 3, 2025, Alexandria, VA —A comprehensive eight-year study examining audiological outcomes of newborns screened for congenital cytomegalovirus (cCMV) through universal screening demonstrates the critical importance of early detection programs in identifying infants at risk for hearing loss. The findings, published in the November 2025 issue of Otolaryngology–Head and Neck Surgery , the peer-reviewed journal of the American Academy of Otolaryngology–Head and Neck Surgery Foundation, reveal that approximately one-third of cCMV-related hearing loss develops after the newborn period—cases that would be missed without universal screening programs.
Congenital cytomegalovirus is the most common non-genetic cause of sensorineural hearing loss (SNHL) in children and can occur even in asymptomatic patients.
“Our study underscores the profound impact of cCMV infection on hearing outcomes, and the importance of universal screening programs to identify infants at risk for sensorineural hearing loss,” said Maria A. Carrillo-Marquez, MD, associate professor in the Department of Pediatrics and Division of Infectious Diseases at The University of Tennessee Health Science Center, in Memphis, Tennessee. “Universal screening is essential to identify babies at risk for hearing loss who would be missed based on symptoms or by newborn hearing screening alone.”
Researchers analyzed data from 247 cCMV-positive newborns identified through saliva PCR screening at three nurseries and a neonatal intensive care unit in Memphis, Tennessee, between March 2016 and May 2024. Among the cohort, 24 infants (approximately 10%) were diagnosed with SNHL, with 16 identified during the immediate neonatal period and eight developing late-onset hearing loss between 6 and 12 months of age. Notably, five of the eight late-onset cases occurred in infants who were asymptomatic at birth.
Connecting Research to Policy
With one in 200 infants born with congenital cytomegalovirus and one in five developing long-term complications such as hearing loss, seizures, and developmental delays, the findings underscore the urgent need for comprehensive screening programs nationwide. The research comes as the American Academy of Otolaryngology–Head and Neck Surgery (AAO-HNS) intensifies efforts to advance cCMV screening legislation at both federal and state levels, making universal newborn cCMV screening a key legislative priority.
“This is one of the Academy's top legislative priorities because the evidence overwhelmingly supports universal screening—we now need legislation to translate this knowledge into action,” said Rahul K. Shah, MD, MBA, AAO-HNS/F Executive Vice President and CEO. “As the physicians who specialize in the diagnosis and treatment of hearing health conditions, we know that screening plays a critical role in facilitating timely intervention. Early diagnosis and treatment of cCMV-related neurodevelopmental health problems are crucial to decreasing the risk of continued hearing loss as well as to the long-term developmental success of children.”
Federal Advocacy: The Stop CMV Act
The Stop CMV Act (H.R. 5435/S. 2842) was successfully reintroduced during the first session of the 119th Congress by U.S. Representatives Mike Lawler (R-NY), Greg Landsman (D-OH), and Deborah Ross (D-NC) and U.S. Senators Richard Blumenthal (D-CT), Roger Marshall, MD (R-KS), and Mark Kelly (D-AZ) thanks to the efforts of AAO-HNS, working in partnership with other key allies and medical societies. This important legislation would authorize federal funding for cCMV screening programs that improve early detection and intervention of hearing loss in infants.
State-Level Progress
The Academy's advocacy efforts are gaining momentum across the country:
“Early diagnosis and treatment of cCMV-related neurodevelopmental health problems are crucial to the long-term developmental success of children,” said Dr. Shah.
Key Study Findings
The Memphis study found that cCMV affected 0.5% of newborns screened—consistent with national estimates—and demonstrated several important findings:
The study also revealed significant challenges with patient follow-up, particularly among families facing socioeconomic barriers. Of the original 247 patients, 137 (55%) were lost to follow-up between the one- and three-month evaluation periods, with the majority occurring in families with higher social vulnerability scores. This underscores the need for comprehensive support systems alongside screening programs.
A Progressive and Often Silent Threat
Congenital cytomegalovirus is the leading infectious cause of birth defects and the leading non-genetic cause of hearing loss in infants. CMV-related hearing loss can be progressive, with approximately 50% of affected children experiencing worsening over time. The hallmark feature of cCMV is progressive and permanent hearing loss, which can present at birth or occur later in life—making universal screening essential for identifying all at-risk infants, not just those with symptoms.
For more information:
Otolaryngology–Head and Neck Surgery
Otolaryngology–Head and Neck Surgery (OTO Journal) is the official peer-reviewed publication of the American Academy of Otolaryngology–Head and Neck Surgery Foundation. Our mission is to publish contemporary, ethical, clinically relevant information in otolaryngology, head and neck surgery (ear, nose, throat, head, and neck disorders) that can be used by otolaryngologists, clinicians, scientists, and specialists to improve patient care and public health.
The AAO-HNS/F is one of the world’s largest organizations representing specialists who treat the ears, nose, throat, and related structures of the head and neck. Otolaryngologist-head and neck surgeons diagnose and treat medical disorders that are among the most common affecting patients of all ages in the United States and around the world. Those medical conditions include chronic ear disease, hearing and balance disorders, hearing loss, sinusitis, snoring and sleep apnea, allergies, swallowing disorders, nosebleeds, hoarseness, dizziness, and tumors of the head and neck as well as aesthetic and reconstructive surgery and intricate micro-surgical procedures of the head and neck. The Academy has approximately 13,000 members. The AAO-HNS Foundation works to advance the art, science, and ethical practice of otolaryngology-head and neck surgery through education, research, and quality measurement.
Otolaryngology
People
Audiological Outcomes of Cytomegalovirus Saliva PCR-Positive Newborns in Support of Universal Screening
12-Jun-2025